From cryoprecipitate to virus-safe high-purity concentrate

Seminars in Thrombosis and Hemostasis

Volumn 28, Issue SUPPL. 1, 2002, Pages 25-29

  Heimburger, Norbert ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BERIATE HS; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; HAEMATE; VON WILLEBRAND FACTOR;

BLOOD COMPONENT THERAPY; CONFERENCE PAPER; CRYOPRECIPITATE; CRYOPRECIPITATION; DRUG RESEARCH; HISTORY OF MEDICINE; HUMAN; PRIORITY JOURNAL; PURIFICATION; VIRAL CONTAMINATION;

EID: 0036240436     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-30192     Document Type: Conference Paper

References (9)

1. The chromatographic separation of F VIII on aminohexyl sepharose
2. High potency anti-haemophilic factor concentrate prepared from cryoglobulin precipitate
3. Frequency of hepatitis B surface antigen antibody in patients of the Heidelberg Hemodialysis Center
4. A factor VIII concentrate, highly purified and heated in solution. 1st International Haemophilia Conference, Bonn, October 3-7, 1980
5. Faktor VIII-konzentrat, hochgereinigt und in lösung erhitzt
6. Inability of pasteurized factor VIII preparations to induce antibodies to HTLV-III after long-term treatment
7. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusion
8. Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate
9. Prevention of hepatitis C virus infection in children with haemophilia A and B and von Willebrand's disease